China Universal Asset Management Company’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Buy |
9,059
+50
| +0.6% | +$14.4K | 0.24% | 86 |
|
|
2025
Q1 | $2.78M | Sell |
9,009
-457
| -5% | -$141K | 0.26% | 83 |
|
|
2024
Q4 | $3.34M | Buy |
9,466
+909
| +11% | +$321K | 0.31% | 68 |
|
|
2024
Q3 | $3.07M | Buy |
8,557
+3,344
| +64% | +$1.2M | 0.34% | 64 |
|
|
2024
Q2 | $1.66M | Sell |
5,213
-3,827
| -42% | -$1.22M | 0.23% | 80 |
|
|
2024
Q1 | $2.08M | Buy |
9,040
+3,603
| +66% | +$828K | 0.26% | 80 |
|
|
2023
Q4 | $1.2M | Buy |
5,437
+4,240
| +354% | +$932K | 0.23% | 95 |
|
|
2023
Q3 | $270K | Buy |
1,197
+582
| +95% | +$131K | 0.08% | 131 |
|
|
2023
Q2 | $136K | Sell |
615
-13
| -2% | -$2.87K | 0.04% | 146 |
|
|
2023
Q1 | $141K | Buy |
628
+165
| +36% | +$37K | 0.05% | 124 |
|
|
2022
Q4 | $129K | Buy |
463
+37
| +9% | +$10.3K | 0.05% | 115 |
|
|
2022
Q3 | $89K | Buy |
+426
| New | +$89K | 0.04% | 114 |
|